No definition available.
Congenital musculoskeletal deformities of head, face, spine and chest
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MUSCULOS_DEFORMITI_HEAD_FACE_SPINE_CHEST
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
463 |
4. Check minimum number of eventsNone |
463 |
5. Include endpointsNone |
463 |
6. Filter based on genotype QC (FinnGen only) |
463 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_DEFORMAT_MUSCULOS_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q6[5-9]|Q7
- Name in latin
- Deformitates musculosceletales congenitae capitis, faciei, columnae vertebralis et thoracis
Similar endpoints
↥List of similar endpoints to
Congenital musculoskeletal deformities of head, face, spine and chest
based on the number of shared cases.
Similar with more cases:
- Congenital malformations and deformations of the musculoskeletal system
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7857 | 2299 | 5551 |
| Only index persons | 5984 | 1736 | 4248 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.13 | 0.07 | 0.16 |
| Only index persons | 0.13 | 0.06 | 0.16 |
| Median age at first event (years) | |||
| Whole population | 12.97 | 11.53 | 13.53 |
| Only index persons | 14.71 | 14.54 | 14.78 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 463 | 205 | 258 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.11 |
| Median age at first event (years) | 21.55 | 27.14 | 17.12 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 408
- Matched controls
- 4082
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q67.6
ICD-10 Finland
Pectus excavatum
2699.0
182.7
163
*
GAF03
NOMESCO Finland
Correction of pectus excavatum
+∞
61.0
57
*
GAF10
NOMESCO Finland
Removal of prosthetic material after correction of malformation of chest wall
+∞
58.8
55
*
Q67.48
ICD-10 Finland
Other specified congenital deformity of skull, face or jaw
+∞
54.4
51
*
Q67.4
ICD-10 Finland
Other congenital deformities of skull, face and jaw
+∞
50.0
47
*
Q67.7
ICD-10 Finland
Pectus carinatum
501.1
46.2
45
*
Q67.0
ICD-10 Finland
Facial asymmetry
+∞
33.8
32
*
DJD20
NOMESCO Finland
Plastic repair of septum of nose
11.1
29.3
57
59
Q67.3
ICD-10 Finland
Plagiocephaly
277.2
26.0
26
*
Q67.5
ICD-10 Finland
Congenital deformity of spine
+∞
25.3
24
*
Q67.40
ICD-10 Finland
Other congenital deformities of skull, face and jaw
+∞
24.2
23
*
Q67.8
ICD-10 Finland
Other congenital deformities of chest
+∞
20.0
19
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
18.2
175
898
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
16.5
140
660
ZXE20
NOMESCO Finland
More than three and less than five hours
3.7
15.5
72
222
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.6
15.4
36
51
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
15.3
151
769
Z31.5
ICD-10 Finland
Genetic counselling
5.0
14.8
49
109
AA6AD
NOMESCO Finland
Cranial bones CT examination
55.3
13.9
16
*
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
16.5
12.3
19
12
ZXE00
NOMESCO Finland
One hour or less
2.2
12.0
175
1048
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
17.0
11.8
18
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
11.7
152
860
K07.10
ICD-10 Finland
Asymmetry of jaw
66.9
11.7
13
*
75630
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Pectus excavatum
+∞
11.5
11
*
DLD20
NOMESCO Finland
Rhinoplasty
36.1
11.3
14
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
25.9
11.2
15
6
ZZG00
NOMESCO Finland
Graft of cartilage
61.6
10.7
12
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
10.5
63
233
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
+∞
10.5
10
*
Q67.2
ICD-10 Finland
Dolichocephaly
+∞
10.5
10
*
EEC05
NOMESCO Finland
Le Fort I osteotomy
41.1
10.0
12
*
N02AX02
ATC
tramadol; systemic, rectal
2.1
9.5
123
685
7548A
ICD-9 Finland
Certain congenital musculoskeletal deformities, Other specified nonteratogenic anomalies[PECTUS EXCAVATUM]
+∞
9.4
9
*
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
16.0
9.1
14
9
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
8.5
85
420
5853
FHL
Anterior thoracoplasty (funnel breast, chicken breast)
+∞
8.4
8
*
GAD00
NOMESCO Finland
Thoracoplasty without plombage
+∞
8.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.3
8.0
40
131
M41.4
ICD-10 Finland
Neuromuscular scoliosis
81.5
7.4
8
*
Q17.2
ICD-10 Finland
Microtia
81.5
7.4
8
*
R4110
NOMESCO Finland
Physiotherapy
2.1
7.4
95
519
Q87.03
ICD-10 Finland
Syndrome Goldenhar
+∞
7.3
7
*
5859
FHL
Other operations in this group (eg removal of fixation plate)
+∞
7.3
7
*
M41.9
ICD-10 Finland
Scoliosis, unspecified
8.2
7.2
15
19
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
20.4
7.2
10
5
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.2
7.0
35
116
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
6.8
85
461
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
6.6
73
375
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
6.5
70
354
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
2.6
6.5
48
202
Q87.09
ICD-10 Finland
Other congenital malformations that mainly affect the appearance of the face
70.9
6.4
7
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
18.4
6.3
9
5
GAF96
NOMESCO Finland
Other correction of malformation of chest wall
+∞
6.3
6
*
Q75.00
ICD-10 Finland
Coronary craniosynostosis
+∞
6.3
6
*
Q87.4
ICD-10 Finland
Marfan syndrome
27.1
6.2
8
*
-69
ICPC
Other reason for encounter NEC
4.3
6.1
21
51
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
6.1
188
1375
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014051) Protein [Presence] in Urine by Test strip
27
58
4.88
12.04
3.1
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
39
125
3.31
10.13
2.9
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
47
211
2.37
6.52
4.2
3.0
ml/min/173m2
61.1
75.7
0.88
13
93
(3022621) pH of Urine by Test strip
41
175
2.47
6.35
3.1
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
55
268
2.19
6.30
4.6
10.2
mmol/l
1.6
0.6
1.06
46
210
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
33
127
2.72
6.28
4.5
12.6
mmol/l
25.2
24.0
1.41
33
121
(3045414) Leukocytes [Presence] in Urine
31
116
2.79
6.22
3.0
1.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
243
1893
1.60
5.74
4.5
5.6
mmol/l
6.1
6.4
1.30
220
1725
(40761535) Cells panel - Urine sediment
45
216
2.20
5.36
4.1
3.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
99
640
1.70
4.83
3.4
2.7
e6/l
5.3
5.0
0.07
94
560
(3030467) Casts [#/volume] in Urine by Automated count
127
876
1.62
4.82
4.2
3.3
e6/l
0.1
0.2
1.32
102
650
(3032080) INR in Blood by Coagulation assay
143
1016
1.59
4.80
6.7
6.7
inr
1.1
1.1
0.03
56
309
(3019550) Sodium [Moles/volume] in Serum or Plasma
386
3460
1.70
4.32
13.0
12.3
mmol/l
139.8
139.6
0.67
376
3361
(3044889) 12 lead EKG panel
246
2003
1.49
4.25
3.3
3.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
134
964
1.55
4.18
4.2
3.3
e6/l
15.0
121.7
0.92
111
733
(3023103) Potassium [Moles/volume] in Serum or Plasma
386
3469
1.68
4.17
13.0
12.3
mmol/l
3.9
3.9
0.35
376
3356
(3014576) Chloride [Moles/volume] in Serum or Plasma
58
341
1.80
3.93
4.0
8.3
mmol/l
105.4
104.4
0.92
58
335
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
405
3705
1.74
3.86
12.9
11.2
mg/l
25.7
21.7
1.44
313
2739
(3002385) Erythrocyte distribution width [Ratio]
369
3300
1.58
3.83
14.8
14.1
%
13.4
13.3
0.37
364
3252
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
340
3001
1.50
3.62
9.6
9.4
ml/min/173m2
97.9
95.3
1.35
280
2355
(36304419) Bacteria [Presence] in Urine
120
875
1.50
3.45
3.8
3.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
150
1153
1.45
3.28
4.5
3.9
e6/l
62.7
67.3
0.04
113
777
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
187
1504
1.41
3.16
6.1
8.3
mmol/l
1.2
1.2
0.50
165
1312
(3007853) Bacteria identified in Skin by Aerobe culture
65
420
1.64
3.15
2.1
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
127
955
1.45
3.10
6.7
8.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
416
3880
1.71
3.09
11.0
9.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
141
2.05
3.02
6.7
14.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
77
526
1.56
2.97
3.2
2.9
e6/l
1.1
0.7
0.34
52
298
(3044640) Blood type and Crossmatch panel - Blood
127
962
1.44
2.97
2.2
2.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
399
3692
1.58
2.95
12.6
12.4
%
40.6
40.8
0.23
330
3095
(3011397) Hemoglobin [Presence] in Urine by Test strip
103
755
1.47
2.85
3.7
3.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
74
506
1.55
2.84
5.1
3.1
ng/l
442.3
695.7
0.31
52
317
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
170
1370
1.38
2.76
5.8
8.3
mmol/l
1.2
1.2
0.54
159
1269
(3024561) Albumin [Mass/volume] in Serum or Plasma
154
1221
1.39
2.76
5.5
5.8
g/l
38.0
37.2
1.06
145
1152
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
102
753
1.45
2.71
2.1
2.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
446
4272
2.20
2.71
17.4
16.2
fl
88.9
89.0
0.06
438
4230
(3026361) Erythrocytes [#/volume] in Blood
446
4273
2.19
2.69
17.5
16.2
e12/l
4.7
4.7
0.09
434
4152
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
140
1100
1.39
2.63
4.1
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
263
2282
1.35
2.62
4.7
3.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
446
4277
2.17
2.61
17.7
16.4
g/l
138.8
138.5
0.17
438
4233
(3007461) Platelets [#/volume] in Blood
445
4266
2.11
2.57
17.5
16.3
e9/l
255.4
256.7
0.17
433
4156
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
73
510
1.51
2.55
3.2
3.1
e6/l
2.9
2.2
0.23
48
284
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
47
297
1.65
2.51
1.8
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
69
2.37
2.51
2.4
7.2
u/ml
0.3
0.4
1.86
11
41
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
250
1.70
2.50
3.1
3.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
445
4273
2.07
2.44
17.5
16.1
pg
29.8
29.9
0.11
437
4231
(3010813) Leukocytes [#/volume] in Blood
445
4275
2.05
2.40
17.6
16.2
e9/l
6.7
6.7
0.02
434
4153
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
81
591
1.45
2.29
3.1
3.4
ng/l
670.3
1189.4
1.02
66
476
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
177
1471
1.33
2.26
3.7
4.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
9
5.60
2.22
2.4
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
47
308
1.59
2.19
1.9
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
26
145
1.84
2.15
3.9
7.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
26
3.11
2.02
1.0
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
61
435
1.46
1.95
1.8
1.8
—
—
—
0
0
(4010399)
34
213
1.64
1.91
1.6
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
403
3814
1.44
1.87
9.4
9.0
u/l
25.8
29.0
3.20
390
3705
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
12
4.20
1.83
1.0
2.4
—
—
—
0
0
(3000492) Spirometry study
52
365
1.48
1.80
1.4
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
101
798
1.34
1.79
3.1
3.6
ph
7.4
7.4
0.42
14
136
(3026008) Bacteria identified in Urine by Culture
98
781
1.32
1.63
2.9
2.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
32
2.53
1.60
1.9
2.6
mmol/l
107.1
105.9
—
8
32
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
32
2.53
1.60
1.9
2.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
32
2.53
1.60
1.9
2.6
mmol/l
4.0
4.0
—
8
32
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
143
0.41
1.54
2.2
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
44
2.30
1.54
1.2
1.7
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.52
1.2
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
15
3.36
1.52
7.4
6.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
21
2.88
1.51
1.5
1.4
g/l
1.0
0.9
—
6
21
(3008295) Osmolality of Serum or Plasma
0
45
0.00
1.50
0.0
1.7
—
287.6
—
0
32
(3019198) Lymphocytes [#/volume] in Blood
220
1956
1.24
1.49
7.0
7.5
e9/l
2.0
2.1
0.34
202
1729
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
40
2.27
1.41
1.0
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
266
2423
1.23
1.40
7.1
7.0
u/l
88.0
85.1
0.33
250
2292
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
342
1.42
1.39
1.8
2.3
nmol/l
15.1
13.9
0.36
41
307
(3034770) Mitochondria Ab [Titer] in Serum
5
123
0.40
1.39
1.4
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
217
1937
1.23
1.38
7.4
8.1
e9/l
0.2
0.2
0.64
198
1700
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
161
0.49
1.38
2.3
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
54
404
1.38
1.36
5.6
8.5
mmol/l
2.2
1.4
1.30
45
311
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
17
2.96
1.36
1.0
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
103
848
1.28
1.35
6.1
4.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
88
710
1.30
1.35
4.4
4.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
211
1882
1.22
1.35
7.2
7.5
e9/l
0.5
0.6
0.67
190
1616
(3006315) Basophils [#/volume] in Blood
211
1886
1.22
1.31
7.2
7.5
e9/l
0.0
0.0
0.66
190
1620
(3013139) Helicobacter pylori Ag [Presence] in Stool
30
202
1.52
1.31
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
106
1262
0.79
1.31
2.5
2.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
6
134
0.44
1.29
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
74
920
0.77
1.29
1.7
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
135
0.44
1.29
1.3
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
48
2.11
1.28
2.3
3.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
41
297
1.42
1.25
9.4
10.8
mmol/l
7.6
6.7
0.38
41
289
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
25
2.42
1.24
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
36
255
1.45
1.24
3.6
2.5
u/l
1730.4
3965.9
0.64
12
114
(3022145) Colonoscopy Study observation
46
341
1.39
1.24
1.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
57
438
1.34
1.23
2.2
2.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
183
1621
1.21
1.23
3.6
3.3
estimate
0.0
0.0
0.00
29
311
(3009261) Glucose [Presence] in Urine by Test strip
185
1642
1.21
1.21
3.7
3.3
estimate
0.0
0.0
0.00
31
310
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
117
992
1.24
1.19
1.5
1.7
pmol/l
106.6
96.7
0.80
54
510
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
22
331
0.65
1.18
1.5
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
10
50
2.02
1.17
1.6
1.3
g/l
0.3
0.3
—
5
38
(4062490)
10
50
2.02
1.17
1.6
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
10
50
2.02
1.17
1.6
1.3
g/l
6.0
6.0
—
5
39
(3028192) IgG subclass 2 [Mass/volume] in Serum
10
50
2.02
1.17
1.6
1.3
g/l
2.7
2.2
—
5
39
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
35
0.00
1.15
0.0
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
237
2161
1.20
1.15
9.1
10.1
e9/l
3.8
3.9
0.39
215
1855
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
46
346
1.37
1.15
6.2
7.3
mmol/l
2.4
1.1
1.12
32
247
(3028626) Oxygen [Partial pressure] in Capillary blood
35
251
1.43
1.14
5.7
7.7
kpa
9.7
9.5
0.37
35
237
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
36
0.00
1.14
0.0
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
182
1622
1.20
1.13
4.9
4.6
estimate
0.0
0.0
0.00
31
323
(3041806) Other cells [#/volume] in Blood by Manual count
8
40
2.02
1.12
1.5
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
51
1.98
1.12
1.3
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
31
2.28
1.10
1.0
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
31
2.28
1.10
5.6
5.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
137
1.56
1.07
1.3
1.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
208
1885
1.19
1.06
7.0
7.6
%
32.4
31.4
0.59
195
1804
(3000991) Gas panel - Venous blood
48
369
1.34
1.05
7.9
9.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
81
669
1.26
1.04
2.2
3.1
umol/l
8820.7
4485.7
0.31
75
599
(40768446) Kidney Pathology biopsy report
5
22
2.29
1.03
1.8
2.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
68
1.79
1.01
1.0
1.2
—
1.1
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
35
2.02
1.00
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
20
132
1.54
0.98
1.9
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
174
0.57
0.98
1.4
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
29
0.00
0.98
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
69
1.76
0.97
1.5
3.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
39
295
1.35
0.96
6.0
7.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
49
384
1.31
0.96
1.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
37
278
1.36
0.95
1.7
1.3
u/ml
879.3
245.9
0.38
37
254
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
6
27
2.24
0.93
1.8
2.3
nmol/l
0.1
0.1
—
6
15
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
29
211
1.40
0.91
1.3
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
160
1.46
0.90
1.5
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
191
1738
1.17
0.89
7.1
7.8
%
0.7
0.7
0.43
182
1654
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
42
1.92
0.89
1.4
1.9
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
6
30
2.01
0.87
49.8
29.4
ug/l
139.0
143.6
—
6
25
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
83
703
1.22
0.87
1.9
2.6
mg/l
0.9
0.9
0.03
54
507
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
64
1.74
0.87
8.2
4.1
e9/l
3.3
4.0
0.78
11
64
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
31
1.95
0.84
2.0
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
140
0.56
0.84
1.9
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
202
1853
1.16
0.84
6.7
7.4
%
52.9
53.9
0.57
192
1775
(3007164) IgA [Mass/volume] in Serum or Plasma
89
1029
0.83
0.82
1.7
1.5
g/l
1.9
2.0
0.41
46
603
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
47
1.71
0.81
3.9
3.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
144
1291
1.17
0.80
6.3
7.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
199
1.38
0.80
4.9
4.7
ug/l
3.0
63.6
0.83
19
157
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
1388.8
—
0
24
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
33
1.83
0.79
1.3
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
25
0.00
0.79
0.0
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
96
0.52
0.79
1.6
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
74
1.64
0.79
1.3
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
195
1792
1.15
0.78
7.2
7.7
%
3.4
3.0
1.10
185
1697
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
34
1.77
0.76
1.2
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
3.5
—
2.8
—
0
28
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
14
91
1.56
0.76
2.4
2.3
ug/l
298.7
327.1
0.08
14
85
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
9
53
1.71
0.76
1.3
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
67
1.66
0.75
8.3
4.4
%
52.5
55.0
0.35
11
67
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
411
0.76
0.75
1.6
1.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
24
2.09
0.74
1.8
5.7
ug/l
20.1
23.1
—
5
24
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
136
0.58
0.74
1.5
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
159
0.62
0.73
1.4
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
106
0.56
0.73
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
275
0.71
0.73
1.5
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
105
926
1.17
0.72
2.1
2.6
u/l
50.9
55.4
0.96
91
866
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
147
1331
1.15
0.72
2.7
2.6
nmol/l
73.7
71.8
0.44
137
1226
(3021589) Normoblasts [#/volume] in Blood
188
1732
1.14
0.72
7.9
9.8
e9/l
0.0
0.0
0.52
159
1365
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
61
512
1.22
0.71
1.3
1.3
iu/ml
40.1
32.7
0.10
21
149
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
9
144
0.62
0.70
1.8
1.9
u/l
35.1
39.5
—
9
133
(3008898) HLA-B27 [Presence]
14
204
0.68
0.70
1.1
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
261
2463
1.14
0.68
4.6
3.9
mm/h
8.2
8.5
0.19
248
2293
(3019069) Monocytes/100 leukocytes in Blood
195
1806
1.14
0.68
7.4
7.9
%
8.5
8.4
0.12
187
1727
(3003694) ABO and Rh group [Type] in Blood
125
1123
1.15
0.68
1.6
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
55
653
0.82
0.67
1.6
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
167
0.65
0.67
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
167
0.65
0.67
1.5
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
18
128
1.42
0.66
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
71
610
1.19
0.66
3.4
2.8
mosm/kgh2o
629.3
575.8
0.51
64
526
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
287
1.28
0.66
1.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
282
2678
1.14
0.66
3.5
3.7
pmol/l
14.6
14.6
0.04
259
2450
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
166
0.65
0.65
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
166
0.65
0.65
1.5
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
26
198
1.33
0.65
2.0
1.8
iu/l
20.0
16.9
0.19
18
156
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
128
0.62
0.65
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
23
173
1.35
0.63
2.3
5.0
s
21.4
22.0
0.34
23
161
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
187
0.69
0.62
1.5
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
28
355
0.78
0.61
1.7
1.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
30
1.67
0.61
1.2
4.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
105
1.44
0.60
1.1
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
21
0.00
0.60
0.0
1.2
—
0.1
—
0
5
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
2.8
—
90.7
—
0
11
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
0
22
0.00
0.59
0.0
1.0
—
101.8
—
0
12
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
173
0.69
0.58
1.8
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
10.4
—
0
23
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
0
23
0.00
0.58
0.0
1.0
—
93.5
—
0
13
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
176
1.32
0.57
2.2
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
11
73
1.52
0.56
1.0
1.2
—
46.6
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
16
217
0.73
0.56
1.6
1.4
—
—
—
0
0
(3020891) Body temperature
15
107
1.42
0.56
3.5
4.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
38
1.59
0.54
1.3
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.4
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
39
1.55
0.53
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
39
1.55
0.53
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
39
1.55
0.53
1.3
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
66
1.53
0.53
1.0
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
492
1.18
0.52
1.3
1.2
u/ml
6.0
9.2
0.32
22
203
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
98
0.61
0.52
1.0
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
102
921
1.14
0.52
4.5
3.1
mmol/l
2.4
2.4
0.17
92
830
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
18
236
0.75
0.52
1.2
1.2
—
32.9
—
0
12
(40765089) Chromosome analysis panel - Blood by G-banded
6
40
1.51
0.51
1.2
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
40
1.51
0.51
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
40
1.51
0.51
1.3
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
23
181
1.28
0.49
1.7
2.8
g/l
69.5
65.5
2.33
23
171
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
46
1.53
0.48
2.0
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
56
487
1.17
0.48
1.4
1.4
titre
365.0
445.3
—
8
90
(3019225) pH of Specimen
29
236
1.24
0.48
4.0
4.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
29
237
1.24
0.46
3.6
2.5
e9/l
3.9
4.1
0.09
22
205
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
129
1.33
0.46
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
198
0.75
0.46
1.3
1.3
miu/ml
218.6
270.7
—
6
101
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
119
0.67
0.46
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
24
297
0.80
0.46
1.3
1.3
iu/ml
40.7
164.1
4.30
11
112
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
23
286
0.79
0.46
1.6
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
50
1.41
0.45
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
57
500
1.16
0.44
1.6
2.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
10
69
1.46
0.44
1.8
3.7
mmol/l
3.8
3.9
—
10
62
(3019832) Treponema pallidum Ab [Presence] in Serum
65
728
0.88
0.43
1.7
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
32
1.57
0.42
1.0
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
150
0.73
0.42
1.8
1.5
u/ml
202.3
212.4
—
6
76
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
4.3
—
87.4
—
0
16
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
3.4
—
87.7
—
0
16
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
16
0.00
0.41
0.0
2.8
—
165.8
—
0
16
(42529406) Shigella sp [Presence] in Stool by Culture
17
132
1.30
0.41
1.1
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
112.6
—
0
17
(3051611) Lipemic interference index of Serum or Plasma
5
35
1.43
0.39
4.6
2.9
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
111
0.72
0.37
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.36
0.37
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.36
0.37
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.36
0.37
1.2
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
71
1.27
0.36
3.2
3.0
u/ml
4.8
62.2
—
9
64
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
97
895
1.11
0.36
2.0
2.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
56
625
0.88
0.36
3.6
3.4
mg/l
28.7
88.1
2.54
37
426
(3035637) Corticotropin [Mass/volume] in Plasma
5
78
0.64
0.36
1.4
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
79
0.63
0.35
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
47
415
1.15
0.35
1.5
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
55
492
1.13
0.34
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
27
228
1.20
0.34
8.6
5.5
ng/l
68.1
67.5
0.02
27
218
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
15
188
0.79
0.34
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
144
0.76
0.34
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
46
1.31
0.33
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
154
0.77
0.32
1.8
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
202
1.20
0.31
2.0
1.9
u/l
4.3
6.3
1.79
15
160
(3021901) Oxygen saturation in Capillary blood
7
52
1.35
0.31
6.6
3.9
—
—
—
0
0
(44790049)
7
53
1.33
0.31
1.4
2.0
—
—
—
0
0
(44790047)
7
53
1.33
0.31
1.4
2.0
—
—
—
0
0
(44790048)
7
53
1.33
0.31
1.4
2.0
—
—
—
0
0
(44806118)
7
53
1.33
0.31
1.4
2.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
244
2521
0.93
0.30
2.7
3.3
u/l
31.3
39.6
3.11
229
2425
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
46
412
1.13
0.29
3.4
2.6
mmol/l
2.4
2.4
0.06
40
356
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
324
3166
1.08
0.29
4.2
4.3
mu/l
1.9
1.9
0.00
302
2936
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
312
0.86
0.29
3.4
3.6
%
33.0
31.0
0.51
21
217
(3000494) Fungus identified in Specimen by Culture
41
365
1.14
0.29
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
85
1.30
0.28
1.4
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
45
404
1.13
0.28
1.6
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
226
0.83
0.28
1.5
2.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
63
1.27
0.28
1.4
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
86
922
0.92
0.28
3.5
3.4
mmol/l
8.7
8.6
0.08
75
823
(3041096) Erythrocytes [Presence] in Urine by Automated
88
941
0.92
0.27
3.0
2.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
37
329
1.14
0.27
1.7
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
67
1.20
0.26
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
67
1.20
0.26
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
77
1.31
0.26
3.3
2.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
169
1.19
0.26
1.1
1.2
u/ml
0.7
2.3
1.30
12
91
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
150
1569
0.93
0.26
5.5
6.8
umol/l
11.7
12.9
0.38
142
1496
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
33
293
1.14
0.25
5.4
6.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
12
96
1.26
0.24
1.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
128
1218
1.07
0.24
1.7
1.8
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
77
1.17
0.24
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
77
1.17
0.24
1.6
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
77
1.17
0.24
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
316
3095
1.07
0.24
3.3
3.2
mmol/l
1.2
1.3
0.26
297
2918
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
103
973
1.08
0.24
2.1
2.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.2
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
43
392
1.11
0.22
2.7
2.5
%
19.9
24.1
1.63
37
353
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
17.8
—
0
10
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
10
0.00
0.21
0.0
1.0
—
165.1
—
0
10
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
27.9
—
0.5
—
0
12
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
43
1.16
0.21
2.6
2.3
—
613.6
—
0
11
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
89
1.24
0.21
1.4
1.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
13
0.00
0.21
0.0
4.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
69
646
1.08
0.21
4.0
4.0
ug/l
1.6
2.1
0.43
64
573
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.3
1.8
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
581.1
—
0
9
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
274.9
—
0
9
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.1
—
2901.2
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
44.6
—
0
8
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
4.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
111
0.81
0.20
1.7
1.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
285
2792
1.05
0.20
4.5
4.3
mmol/mol
37.7
38.0
0.27
276
2642
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
146
1.17
0.19
1.2
1.2
u/ml
1.2
1.4
0.05
11
94
(3011288) Drugs identified in Urine by Screen method
32
289
1.12
0.19
2.3
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
122
0.82
0.19
3.4
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
26
232
1.13
0.19
1.2
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
109
1.20
0.18
1.4
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
81
854
0.94
0.18
4.2
3.4
estimate
0.0
0.0
0.50
28
316
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
121
0.82
0.18
3.4
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
10
82
1.22
0.17
1.6
1.9
g/l
1.3
0.8
—
5
69
(3016244) Insulin [Units/volume] in Serum or Plasma
7
63
1.11
0.17
2.0
2.9
mu/l
10.7
29.3
—
7
58
(3024928) Oxygen saturation in Venous blood
8
69
1.16
0.16
2.4
13.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
183
0.87
0.16
2.1
2.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
22
245
0.89
0.16
2.5
4.6
e9/l
65.7
70.6
0.33
15
172
(40768804) Tissue Pathology biopsy report
111
1153
0.95
0.15
1.8
1.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
77
0.78
0.15
1.5
1.3
ug/l
17.9
3.5
—
6
70
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
73
767
0.94
0.15
1.7
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
122
1263
0.95
0.15
3.8
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
14
121
1.16
0.15
1.8
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
100
962
1.05
0.14
2.8
3.0
ng/l
19.7
31.1
1.09
56
527
(3021960) Folate [Moles/volume] in Serum or Plasma
54
571
0.94
0.14
1.4
1.4
nmol/l
21.8
19.5
0.62
46
490
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
100
0.80
0.13
1.3
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
10
117
0.85
0.13
1.2
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
106
0.85
0.13
1.1
1.1
—
9.5
—
0
6
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
152
1.12
0.12
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
307
3032
1.04
0.12
3.4
3.4
mmol/l
5.6
5.7
0.17
286
2797
(3019150) Specific gravity of Urine by Refractometry
75
781
0.95
0.12
3.9
3.2
kg/l
1.0
1.0
0.30
11
110
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
10
116
0.86
0.12
3.4
1.6
—
95.9
—
0
18
(3013512) EKG study
75
720
1.05
0.12
3.4
3.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
39
414
0.94
0.11
1.5
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
367
1.07
0.11
2.8
2.6
ug/l
0.7
0.7
0.07
25
204
(3002179) Metamyelocytes/100 leukocytes in Blood
27
250
1.08
0.11
5.2
4.7
%
0.2
0.4
—
5
59
(3027944) Amphetamines [Presence] in Urine
45
427
1.06
0.10
1.7
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
28
261
1.08
0.10
6.3
5.0
%
0.0
0.2
—
6
76
(36660697) Celiac disease serology panel - Serum
40
422
0.94
0.10
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
106
1.14
0.10
1.4
2.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
115
1180
0.97
0.10
1.9
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
48
1.04
0.09
1.6
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
45
429
1.05
0.09
1.7
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
54
1.11
0.09
1.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
6
54
1.11
0.09
2.3
1.6
g/l
0.0
0.0
—
6
54
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
54
1.11
0.09
1.3
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
6
54
1.11
0.09
2.3
1.6
g/l
0.0
0.0
—
6
54
(4306422)
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
61
632
0.96
0.08
2.8
3.0
ug/g
92.9
136.8
0.60
52
513
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
115
1124
1.03
0.08
1.6
1.5
u/ml
0.8
2.4
2.03
25
269
(3020682) Albumin/Creatinine [Ratio] in Urine
63
652
0.96
0.08
4.2
4.2
mg/mmol
6.2
38.7
0.70
43
446
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
64
1.10
0.08
1.1
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
67
1.05
0.08
2.1
1.5
g/l
3.1
2.9
—
7
60
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
323
3256
0.97
0.07
3.8
3.7
mmol/l
2.7
2.8
0.81
302
3052
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
72
0.83
0.07
1.0
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
74
1.08
0.07
2.0
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
75
1.07
0.07
5.4
2.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
45
432
1.05
0.07
1.7
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
16
147
1.09
0.07
1.1
1.2
u/ml
0.9
4.0
—
8
47
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
82
0.85
0.07
5.4
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
45
434
1.04
0.06
1.7
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
29
276
1.05
0.06
6.1
4.9
%
0.2
1.0
—
6
83
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
333
3309
1.02
0.06
3.5
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
62
603
1.03
0.06
1.5
1.8
%
1.4
1.4
0.09
57
547
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
19
178
1.07
0.05
12.8
13.6
mg/l
1.4
1.2
0.73
19
170
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
297
1.05
0.05
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
49
504
0.97
0.04
3.5
3.8
%
27.6
20.1
1.07
18
199
(3019309) Folate [Moles/volume] in Red Blood Cells
40
387
1.04
0.04
1.9
1.6
nmol/l
1017.1
1195.2
0.56
23
311
(3001019) Free T4 and TSH panel - Serum or Plasma
20
211
0.95
0.04
1.5
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
10
91
1.10
0.04
1.7
2.4
nmol/l
0.8
0.7
—
10
78
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
160
1.06
0.04
1.5
1.5
mg/l
4.6
3.4
0.36
12
108
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
78
792
0.98
0.03
1.5
1.7
mmol/l
1.3
1.3
0.02
67
701
(3003740) Influenza virus B Ag [Presence] in Specimen
11
118
0.93
0.03
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
118
0.93
0.03
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
31
318
0.97
0.02
1.4
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
79
797
0.99
0.01
2.4
2.6
mg/l
2.6
2.9
0.78
68
707
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
322
3213
1.01
0.01
3.6
3.5
mmol/l
1.4
1.4
0.00
304
3028
(4034850)
11
116
0.95
0.00
8.2
11.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
162
1613
1.01
0.00
2.8
2.9
ug/l
81.4
91.3
0.53
150
1519
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
12
126
0.95
0.00
1.3
1.6
—
192.0
—
0
5
(3025159) Blasts/100 leukocytes in Blood
26
254
1.03
0.00
6.5
5.0
%
0.0
0.0
—
5
65
(21494755) Public health laboratory ask at order entry panel
53
536
0.99
0.00
1.3
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
16
155
1.03
0.00
2.5
3.1
e6/l
0.0
0.1
2.05
16
147
(1002224) Polysomnography panel
16
164
0.97
0.00
1.2
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
32
315
1.02
0.00
3.2
5.2
u/l
221.5
253.3
1.34
32
304
(4035726)
23
227
1.01
0.00
1.2
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
278
1.01
0.00
4.2
3.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
323
3233
1.00
0.00
3.6
3.5
mmol/l
4.5
4.6
1.25
309
3054
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
81
0.99
0.00
2.0
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
57
0.88
0.00
1.0
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
6
69
0.87
0.00
1.0
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(4094501)
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
61
0.98
0.00
7.3
4.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
9
0.00
0.00
0.0
10.6
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
4.8
—
0
5
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
14.3
—
0
5
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.2
—
1.1
—
0
9
(3001186) Copper [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
22.1
—
0
8
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
271.0
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
86
0.93
0.00
1.3
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.1
—
2.9
—
0
8
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
130
1.00
0.00
1.2
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4268621)
5
51
0.98
0.00
3.6
2.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
6
59
1.02
0.00
2.3
1.6
g/l
0.0
0.0
—
6
59
(44806071)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
66
0.91
0.00
4.8
4.8
umol/l
297.6
386.9
—
6
60
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
59.2
—
0
6
(3052851) Hemolysis interference index of Serum or Plasma
9
97
0.93
0.00
4.6
2.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MUSCULOS_DEFORMITI_HEAD_FACE_SPINE_CHEST and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_MUSCULOS_DEFORMITI_HEAD_FACE_SPINE_CHEST | 1.107 [0.86, 1.42] | 0.422 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 4624 males with Q17_CONGEN_MUSCULOS_DEFORMITI_HEAD_FACE_SPINE_CHEST died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MUSCULOS_DEFORMITI_HEAD_FACE_SPINE_CHEST.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.219% |
| 5 | No data | 1.212% |
| 10 | No data | 3.016% |
| 15 | No data | 5.71% |
| 20 | No data | 9.419% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MUSCULOS_DEFORMITI_HEAD_FACE_SPINE_CHEST – Congenital musculoskeletal deformities of head, face, spine and chest
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data